Dr. Paul Moore Named Recipient of the ADA’s Norton M. Ross Award for Excellence in Clinical Research
In a career spanning some four decades, Paul A. Moore, D.M.D., Ph.D., M.P.H., has stood at the forefront of dental research in the realms of analgesics and anesthesia, working to eradicate suffering and phobia in dental patients. In recognition of his laudable career and his many successes, the American Dental Association (ADA) has named Dr. Moore recipient of the 2013 Norton M. Ross Award for Excellence in Clinical Research.
A Professor and former Chair of the Department of Dental Anesthesiology at the University of Pittsburgh School of Dental Medicine, he started in dentistry with a private practice in Oakmont, PA. He soon turned to the academic setting and over the following 40 years earned many laurels in clinical research and spurred the advancement of safety and efficacy of drug therapy in dentistry.
“I have always been an inquisitive kind of person and I love research,” Dr. Moore says. “I am delighted and always a bit surprised to see that my work has had an impact on dental practice. It’s been a real joy. I’ve been fortunate enough to work at institutions like the University of North Carolina, Harvard, Forsyth and, of course, the University of Pittsburgh that have been willing to support me to pursue new knowledge and its application into the clinical setting of dentistry.”
Dr. Moore graduated from the University of Pittsburgh School of Dental Medicine with a dental degree and Ph.D. in pharmacology. He later earned an M.P.H. in epidemiology at the Graduate School of Public Health at the University of Pittsburgh.
His clinical expertise and areas of research include the safe use of local anesthetics in pediatric dentistry; pain management using long-acting local anesthetics; the development and U.S. Food and Drug Administration approval of the local anesthetic, articaine; the efficacy of the novel local anesthetic reversal agent, phentolamine; safe and effective use of nitrous oxide–oxygen analgesia and oral sedatives for pediatric dental patients; clinical utility of transmucosal fentanyl; effective intravenous sedation in adults; and the efficacy of flumazenil for reversal of benzodiazepines.
His many accolades include serving as principal investigator or co-investigator on more than 40 clinical research projects sponsored by the National Institutes of Health and private industry. He also has authored more than 250 articles, books, chapters and research abstracts on clinical pharmacology and dental therapeutics and presented his research findings in more than 150 invited lectures nationally and internationally on local anesthesia, antibiotics, analgesics, sedation, drug interactions and oral complications of diabetes. Dental reviewers, book authors and others often cite his clinical research findings.
“At every turn, Dr. Moore has demonstrated resoluteness in finding solutions to some of the greatest challenges associated with dental pain management and dental fear and anxiety,” says ADA President Robert Faiella. “He brings a thoughtful and probing mind to his approach to clinical research, and he fully deserves to be honored with the 2013 Norton M. Ross Award for his many career accomplishments.”
The ADA has presented the Norton M. Ross Award annually since 1991 to recognize investigators whose research has significant impact on some aspect of clinical dentistry. The late Dr. Norton M. Ross was a dentist and pharmacologist who made significant contributions to oral medicine and dental clinical research.
The ADA sponsors the award in Dr. Ross’ honor with support from Johnson & Johnson Healthcare Products Division of McNEIL-PPC Inc., the makers of LISTERINE and REACH products.